Introduction

Sympathetic crashing acute pulmonary edema (SCAPE) is a form of hypertensive heart failure triggered by a surge in catecholamines, resulting in pulmonary capillary leakage and rapid alveolar flooding. This life-threatening presentation requires immediate intervention — typically combining non-invasive ventilation with pharmacologic agents.

Key Concept

  • SCAPE is a form of hypertensive heart failure triggered by a surge in catecholamines
  • The result is pulmonary capillary leakage and alveolar flooding
  • Management includes non-invasive ventilation and pharmacologic agents such as nitroglycerin
  • Dose-dependent afterload reduction with nitroglycerin requires doses >50–150 mcg/min

Pharmacology of Nitroglycerin (NTG)

Parameter Details
Mechanism of Action
Organic nitrate vasodilator that reduces tension on vascular smooth muscle and dilates peripheral veins and arteries (at higher doses).
Dose

Chest pain: 5–400 mcg/min (starting at 5 mcg/min)

Pulmonary edema / afterload reduction: 50–400 mcg/min

Titrate to symptom improvement and tolerated blood pressure
Administration

IV Infusion

50–400 mcg/min until symptom resolution

IV Bolus

400–2000 mcg over 2–5 min

Sublingual

400 mcg tab, 2–4 tablets (≈160–320 mcg/min IV)

Ointment

Slow onset 30–60 min
PK/PD
Onset: IV 1–5 min; SL 1–3 min Peak: 3–15 min Duration: IV 5–10 min; SL 10–60 min Elimination: 22% renal
Adverse Effects
Headache Hypotension Syncope Rebound HTN Tolerance (~24 hrs)
Warnings

Contraindicated with: PDE inhibitors, aortic stenosis, preload-dependent cardiomyopathy, HOCM, hypotension at any time
Compatibility
Incompatible with levofloxacin, SMX-TMP, daptomycin, and phenytoin

Clinical Pearl

Higher doses of IV or bolus nitroglycerin may reduce ICU admissions and intubation risk in SCAPE.

Overview of Key Evidence

Author / Year Design (n) Intervention Key Findings
Patrick, 202016 Observational
n=48 		IV NTG 1 mg bolus by EMS
↓ SBP 31 mmHg ↓ HR 10 bpm ↑ O₂ 86%→98%

2% symptomatic hypotension
Hsieh, 201810 Case Report
n=3 		SL NTG 0.6 mg ×3, IV NTG bolus 1 mg Q2 min, then infusion 40 mcg/min Normalized respiratory status, avoided intubation & ICU admission
Paone, 201815 Case Report
n=1 		IV NTG 400 mcg/min titrated Symptom resolution at 6 min
Wilson, 201611 Observational
n=395 		IV NTG bolus (500–2000 mcg) Q3–5 min vs infusion vs both
↓ ICU admissions ↓ LOS

No increase in intubations
Levy, 200712 Observational
n=29 		IV NTG bolus 2 mg IV Q3 min
↓ Intubation ↓ BiPAP/ICU
Sharon, 200013 RCT
n=40 		IV isosorbide bolus 4 mg Q4 min vs infusion + BiPAP
↓ Intubation ↓ MI ↓ Mortality ↑ PaO₂
Cotter, 199814 RCT
n=104 		IV isosorbide bolus 3 mg Q5 min + furosemide vs infusion titration
↓ MV & MI ↑ PaO₂

Fewer adverse effects

Clinical Conclusions

Bottom Line

High-dose nitroglycerin (bolus and/or infusion) is effective in rapidly reducing preload and afterload in SCAPE, with bolus strategies potentially outperforming continuous infusions.

Doses of ≥400 mcg/min (or equivalent bolus) are supported by case reports and observational studies.

High-dose IV or sublingual NTG has been associated with improved respiratory status, fewer ICU admissions, and reduced need for intubation.

Symptomatic hypotension is rare but monitoring is necessary, especially with bolus regimens.

Bolus dosing strategies may outperform continuous infusions in acute SCAPE decompensation.

Full Reference List

  1. Nitroglycerin. Micromedex [Electronic version]. Greenwood Village, CO: Truven Health Analytics. Retrieved March 5, 2020.
  2. Kramer K. Am Heart J. 2000;140:451–5.
  3. Agrawal N. Crit Care Med. 2016;20:39–43.
  4. Mebazaa A. Eur J Heart Fail. 2015;17:544–58.
  5. Viau DM. Heart. 2015;101:1861–7.
  6. McMurray JJ. Eur J Heart Fail. 2012;14:803–69.
  7. López-Rivera F. Am J Case Rep. 2019 Jan 21;20:83–90.
  8. Clemency BM. Prehosp Disaster Med. 2013 Oct;28(5):477–81.
  9. Yancy CW. J Am Coll Cardiol. 2013;62:e147–239.
  10. Hsieh Y. Turk J Emerg Med. 2018;18(1):34–36.
  11. Wilson SS. Am J Emerg Med. 2017;35(1):126–31.
  12. Levy P. Ann Emerg Med. 2007;50:144–52.
  13. Sharon A. J Am Coll Cardiol. 2000;36(3):832–7.
  14. Cotter G. Lancet. 1998;351(9100):389–93.
  15. Paone S. Am J Emerg Med. 2018;36(8):1526.e5–1526.e7.
  16. Patrick C. Prehosp Emerg Care. 2020 Jan 27:1–7.
Tags: Cardiology High-Dose Nitroglycerin SCAPE Emergency Pharmacotherapy Pharmacy Friday Pearls

Never Miss a Pearl

Get Pharmacy Pearls delivered weekly

Join 3,000+ pharmacists who receive curated clinical insights every Friday.

Start Free Trial